Press release

BERLIN / MUNICH – 25 November 2019 – The global pharmaceutical company and service partner Inceptua Group (previously Multipharma GmbH) and Bendalis GmbH – German manufacturer of generic oncology drugs…

LUXEMBOURG – 11 December 2019 – Inceptua announced today that Stefan Fraenkel has been appointed CEO effective 1 January 2020. Alan Raffensperger is appointed Executive Vice-Chairman of the Inceptua Group.…

“Clive joining the team to focus on patient access strengthens our commercialization capabilities, offering even greater support to our partner companies as they try to reach patients in need,” says…

LUXEMBOURG – 10 October 2018 Inceptua Group today announces that Maria Eklind-Cervenka joins as new Chief Medical Officer (CMO). “With Maria joining we are increasing our Medical Leadership, continuing to…

Key appointments strengthen full lifecycle support for pharma LUXEMBOURG – 5 September 2018 – Inceptua Group (previously Multipharma) today announces the strengthening of its Commercial, Strategy, and Supply Chain teams…

LUXEMBOURG – 23 APRIL 2018 – Inceptua Group (previously Multipharma) today announces that its Clinical Trial Supplies business unit is rebranding to Inceptua Clinical Trial Services. Going forward, all of…

LUXEMBOURG – 1 JUNE 2017 - Multipharma Group today announces the launch of Inceptua Medicines Access, a new speciality business unit that is offering a transformational approach to providing access…